Input or output interoperability
DICOM is explicitly referenced in the described input, output, or workflow.
exact submission · checked 2026-09-01The model card does not establish every supported DICOM object, transfer method, or local interface.
FDA-cleared profile
Caption Interpretation Automated Ejection Fraction Software
Caption Health
Authorized purpose: Processes previously acquired transthoracic cardiac ultrasound images to estimate left-ventricular ejection fraction and assist clinician cardiac evaluation.
Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Authorized purpose: Processes previously acquired transthoracic cardiac ultrasound images to estimate left-ventricular ejection fraction and assist clinician cardiac evaluation.
Overview status: Source-reviewed overview
- What does this software do? Authorized purpose: Processes previously acquired transthoracic cardiac ultrasound images to estimate left-ventricular ejection fraction and assist clinician cardiac evaluation.
- Which images or clinical context are in scope? Modality: Ultrasound Anatomy or clinical context: Heart/Cardiovascular; left ventricle and transthoracic cardiac views Input: Previously acquired transthoracic cardiac ultrasound images, including supported apical four-chamber, apical two-chamber, and parasternal long-axis/apical views.
- Who uses it? Intended users: Clinicians.
- What does the software produce? Output: Whole-number ejection-fraction percentage, confidence indication or qualitative likelihood bin, and an associated video clip.
- What is its most important limitation? Key limitation: Intended for adult patients; no additional limitation was stated in the supplied FDA text.
Clinical takeaway
Clinical role: Processes previously acquired transthoracic cardiac ultrasound images to estimate left-ventricular ejection fraction and assist clinician cardiac evaluation.
Evidence takeaway
Evidence from the reviewed source record: FDA-reported nonclinical verification and validation plus retrospective non-interventional validation of more than 186 acquired studies against a biplane method-of-disks reference.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
- Exact purpose
- Processes previously acquired transthoracic cardiac ultrasound images to estimate left-ventricular ejection fraction and assist clinician cardiac evaluation.
Clinical-use display mirrors the exact FDA-supported purpose reconciled in this remediation finding.
- Intended users
- Clinicians.
FDA packet intended-user statement.
- Care setting and population
- Adult
Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.
- Workflow role
- Measurement or quantification
Conservative normalization of explicit wording in an exact-submission source.
- Required input
- Previously acquired transthoracic cardiac ultrasound images, including supported apical four-chamber, apical two-chamber, and parasternal long-axis/apical views.
FDA packet input scope.
- Output and human action
- Whole-number ejection-fraction percentage, confidence indication or qualitative likelihood bin, and an associated video clip.
FDA packet output scope.
- Limitations
- Intended for adult patients; no additional limitation was stated in the supplied FDA text.
Exact packet boundary.
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
- FDA submission
- K210747
- Modality
- Ultrasound
FDA packet transthoracic cardiac ultrasound scope.
- Anatomy
- Heart/Cardiovascular; left ventricle and transthoracic cardiac views
Exact FDA cardiac scope.
- Clearance type
- 510(k)
- Decision date
- 2022-01-19
- FDA status
- FDA-cleared
Implementation
Questions for IT, informatics, and operations
Use these fields to structure a vendor demo, security review, and implementation estimate.
- Integration
- The exact-submission ACR model card explicitly references DICOM and PACS in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.
- Deployment and data flow
- Vendor documentation pending
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
- Security and privacy
- Vendor documentation pending
Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
- Training and support
- Vendor documentation pending
Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
- Monitoring and change control
- Vendor documentation pending
Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Supported acquisition environment
Scanner manufacturers: All
exact submission · checked 2026-09-01Confirm currently supported software versions, protocols, and site-specific acquisition configurations.
ACR exact-submission catalog context
ACR AI Central provides an exact-submission model card for Caption Interpretation Automated Ejection Fraction Software; FDA labeling remains controlling for clinical use, limitations, and performance.
exact submission · checked 2026-09-09Evidence
Performance evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
- Evidence summary
- FDA-reported nonclinical verification and validation plus retrospective non-interventional validation of more than 186 acquired studies against a biplane method-of-disks reference.
Submission evidence only; not an independent performance claim.
- Reported sensitivity
- Research pending
This field has not been curated yet.
- Reported specificity
- Research pending
This field has not been curated yet.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
Caption Interpretation Automated Ejection Fraction Software regulatory performance study summary
- DesignStand-Alone Performance
- PopulationAdult
- Scopeexact submission
- Tested versionExact product version not reported; regulatory study summarized for FDA submission K210747
- Samplen=186
- IndependenceIndependence not established
K210747
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Costs and setup
Budget and ongoing governance
These are common procurement questions; unknown values remain visible until a source supports them.
- Pricing and total cost
- Vendor documentation pending
No public price or quote for the exact K210747 configuration was established in this review.
- Reimbursement and coding
- Not established in reviewed sources
No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
- Postmarket safety review
- The exact-identifier FDA recall query returned no native recall record for K210747. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Buyer worksheet
Open questions to take to the vendor
- Verify deployment and data flow: The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
- Verify security and privacy controls: Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.
- Verify training: Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.
- Verify pricing and total cost: No public price or quote for the exact K210747 configuration was established in this review.
- Verify reimbursement and coding relevance: No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.
- Verify local validation and lifecycle monitoring: Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.
Research record
What has been checked
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
24Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, fda decision summary packet, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history
Source ledger
-
FDA K210747: Caption Interpretation Automated Ejection Fraction Software
Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, purpose, intendedUsers, input, output, limitations, evidenceSummary
-
Artificial Intelligence-Enabled Medical Devices
Scope: regulatoryIdentity, modalityContext
-
Caption Interpretation Automated Ejection Fraction Software model card (K210747)
Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities
-
PubMed biomedical literature index
Scope: evidenceDiscovery
-
ClinicalTrials.gov study registry
Scope: evidenceDiscovery, studyStatus
-
openFDA Device Recall API
Scope: recallDiscovery, nativeSubmissionMatching
-
openFDA exact recall query for K210747
Scope: postmarketSafety
Research history
-
K210747 FDA decision
Regulatory record
510(k)
-
Source-review record updated
Research record
fda record reviewed
-
Reader overview source-reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Related tools to compare
FDA-cleared K260667
Alturion Series Diagnostic Ultrasound System
Philips Ultrasound, LLC
Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric,...
- Modality
- Ultrasound
- Anatomy
- Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
- Decision
- 2026-06-29
FDA-cleared K260844
ACUSON Sequoia Diagnostic Ultrasound System;ACUSON Sequoia Select Diagnostic Ultrasound System;ACUSON Origin Diagnostic Ultrasound System;ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions USA, Inc.
ACUSON Sequoia, Select, Origin, and Origin ICE diagnostic ultrasound systems acquire and display the labeled fetal, abdominal, pediatric, neonatal, cephalic, small-part,...
- Modality
- Ultrasound
- Anatomy
- Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; transesophageal and intracardiac applications
- Decision
- 2026-06-16
FDA-cleared K260300
WatchMate Software
Anumana, Inc.
WatchMate Software v1.2.0 processes transesophageal echocardiography data to reconstruct the left atrial appendage and assist preprocedural planning and device sizing during...
- Modality
- Ultrasound
- Anatomy
- Heart and left atrial appendage
- Decision
- 2026-06-15
FDA-cleared K260780
HeartFocus
Deski
Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require...
- Modality
- Ultrasound
- Anatomy
- Heart/Cardiovascular
- Decision
- 2026-06-03